glp-1 eligibility criteria Criteria: Who Qualifies for Treatment employerbenefits #glp1 #utilizationmanagement #healthplans #9amhealth

References FDA Label for Wegovy (Semaglutide) FDA Label for Adipex-P (Phentermine) STEP Clinical Trial NEJM Phentermine Efficacy & Safety Review Disclaimer: This article is for educational purposes only

FDA described the clinical evidence as inconclusive and preliminary and identified product-characterisation, aggregation, immunogenicity and safety uncertainties

To help manage nausea, people might try: Avoiding fatty, spicy or greasy foods

ANDREW HUBERMAN: Ugh

Limitations 1 : 1 : Results should be interpreted with caution because of the retrospective pre-post design without a control or comparator arm and the relatively short follow-up (6 months) Hypoglycemia may have been underreported, as only the clinically significant events were likely to have been captured (eg, no SMBG or CGM data) EMR database analysis as a potential for selection bias that cannot be controlled, as well as EMR data-capture challenges (eg, coding errors, no dosing data) Patients were mainly from the Northwest and Southern US states and therefore may not be representative of the US national landscape Sanofi-sponsored study *Follow-up period 6 months included GLP-1 RA + Toujeo (N=271)